WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American ...
The review article titled“Sexual dysfunction after Rezum therapy for benign prostatic hyperplasia: A scoping review for the current insights and findings”, was published on December 10, 2024 in ...
LAS VEGAS -- A novel, non-ablative intervention for lower urinary tract symptoms (LUTS) produced rapid, durable symptom relief with no adverse effect on sexual function, long-term results from ...
UroLift is a minimally invasive treatment for Benign Prostatic Hyperplasia, a condition that causes an enlarged prostate in men. The procedure uses tiny implants to lift and hold the enlarged prostate ...
Teleflex TFX recently announced the upcoming full market release of the Advanced Tissue Control (“ATC”) feature on its unified UroLift 2 System — a platformdesigned for the treatment of benign ...
Rezum water vapor therapy for lower urinary tract symptoms related to benign prostatic hyperplasia (also known as an enlarged prostate) is usually covered by both Original Medicare (parts A and B) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results